UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis

Utidelone injectable has received FDA orphan drug designation for patients with breast cancer brain metastases.

Related Keywords

Biostar Pharma ,Biostar Pharma Inc , ,Response Assessment ,Fda ,Breast Cancer Brain Metastases ,Fda Orphan Drug Designation ,Utidelone Injectable ,